Infliximab (Remicade), which targets the cytokine tumor necrosis factor [TNF]-), and rituximab (Rituxan), which targets a protein on certain immune cells, have been shown to reduce the number of inflammatory cells in the cochlea and thereby stabilize hearing in patients with autoimmune hearing loss
El frmaco es el motor, pero el estilo de vida es el mapa Es vital entender que, aunque el frmaco para adelgazar es extremadamente relevante, no es una solucin mgica ni debe usarse de forma aislada
Support fat metabolism during rest Fucoxanthin from wakame and green tea contribute to fat oxidation and metabolic balance overnight
Mahalingam S, Bellamkonda R, Arumugam MK et al (2023) Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease